Complementary Use of Carbohydrate Antigens Lewis a, Lewis b, and Sialyl-Lewis a (CA19.9 Epitope) in Gastrointestinal Cancers: Biological Rationale towards a Personalized Clinical Application
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Complementary Use of Carbohydrate Antigens Lewis a, Lewis b, and Sialyl-Lewis a (CA19.9 Epitope) in Gastrointestinal Cancers: Biological Rationale towards a Personalized Clinical Application
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 6, Pages 1509
Publisher
MDPI AG
Online
2020-06-10
DOI
10.3390/cancers12061509
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Adenocarcinoma
- (2020) Amr I. Al Abbas et al. ANNALS OF SURGICAL ONCOLOGY
- The physiological and pathological roles and applications of sialyl Lewis x, a common carbohydrate ligand of the three selectins
- (2020) Fanqi Jin et al. GLYCOCONJUGATE JOURNAL
- Identifying Novel Genetic Markers Through Transcription-Wide Association Study: Can This Be A Path To Reducing The Burden of Pancreatic cancer?
- (2020) Jeanine M Genkinger et al. JNCI-Journal of the National Cancer Institute
- Immunohistochemical analysis of IDH2 R172 hotspot mutations in breast papillary neoplasms: applications in the diagnosis of tall cell carcinoma with reverse polarity
- (2020) Fresia Pareja et al. MODERN PATHOLOGY
- Recurrent KRAS mutations identified in papillary renal neoplasm with reverse polarity—a comparative study with papillary renal cell carcinoma
- (2020) Sung Sun Kim et al. MODERN PATHOLOGY
- SSEA3 and Sialyl Lewis a Glycan Expression Is Controlled by B3GALT5 LTR through Lamin A-NFYA and SIRT1-STAT3 Signaling in Human ES Cells
- (2020) Bi-He Cai et al. Cells
- ASO Author Reflections: Serum CA19-9 Utility in Pancreatic Adenocarcinoma in Patients Undergoing Neoadjuvant Therapy
- (2020) Amr I. Al Abbas et al. ANNALS OF SURGICAL ONCOLOGY
- Urinary carbohydrate antigen 19-9 level as a biomarker in children with acute pyelonephritis
- (2020) Abdol-Mohammad Kajbafzadeh et al. EUROPEAN JOURNAL OF PEDIATRICS
- Prognostic and predictive factors in pancreatic cancer
- (2020) Emanuela Dell’Aquila et al. Oncotarget
- Nucleolin-Sle A Glycoforms as E-Selectin Ligands and Potentially Targetable Biomarkers at the Cell Surface of Gastric Cancer Cells
- (2020) Elisabete Fernandes et al. Cancers
- Diagnostic Significance of Serum IgG Galactosylation in CA19-9-Negative Pancreatic Carcinoma Patients
- (2019) Ailing Zhong et al. Frontiers in Oncology
- Duct‐obstructive pancreatitis with granulocytic epithelial lesion in a patient with ulcerative colitis: An atypical manifestation of type 2 autoimmune pancreatitis?
- (2019) Soomin Ahn et al. PATHOLOGY INTERNATIONAL
- The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice
- (2019) Dannielle D. Engle et al. SCIENCE
- Antibodies targeting sialyl Lewis A mediate tumor clearance through distinct effector pathways
- (2019) Polina Weitzenfeld et al. JOURNAL OF CLINICAL INVESTIGATION
- Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients with Pancreatic Cancer
- (2019) Toshiya Abe et al. Clinical Gastroenterology and Hepatology
- A Transcriptome-Wide Association Study (TWAS) Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer
- (2019) Jun Zhong et al. JNCI-Journal of the National Cancer Institute
- Clinicopathological characteristics of gastric cancer with carbohydrate antigen 19‐9 expression occurring in elderly individuals: An autopsy study
- (2019) Tan Wang et al. PATHOLOGY INTERNATIONAL
- Intrahepatic Cholangiocarcinomas Have Histologically and Immunophenotypically Distinct Small and Large Duct Patterns
- (2018) Carlie S. Sigel et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Staining of E-selectin ligands on paraffin-embedded sections of tumor tissue
- (2018) Mylène A. Carrascal et al. BMC CANCER
- Prognostic biomarkers for cholangiocarcinoma and their clinical implications
- (2018) Charupong Saengboonmee et al. Expert Review of Anticancer Therapy
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- Carbohydrate antigen 19-9 is significantly elevated in autosomal dominant polycystic kidney disease
- (2018) Hirotaka Fukasawa et al. NEPHROLOGY
- Associations between CA19‑9 and CA125 levels and human epidermal growth factor receptor 2 overexpression in patients with gastric cancer
- (2018) Hongbo Zhou et al. Oncology Letters
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- Selecting chemotherapy for pancreatic cancer: Far away or so close?
- (2018) Si Shi et al. SEMINARS IN ONCOLOGY
- Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis
- (2017) Julia Mayerle et al. GUT
- The significance of serum IgG4 and CA19-9, autoantibodies in diagnosis and differential diagnosis of IgG4-related sclerosing cholangitis
- (2017) Liming Tan et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers
- (2017) Jungsun Kim et al. Science Translational Medicine
- Comparing the diagnostic accuracy of five common tumour biomarkers and CA19-9 for pancreatic cancer: a protocol for a network meta-analysis of diagnostic test accuracy
- (2017) Long Ge et al. BMJ Open
- Use of Tumor Markers in Gastrointestinal Cancers: Surgeon Perceptions and Cost-Benefit Trade-Off Analysis
- (2016) Amish Acharya et al. ANNALS OF SURGICAL ONCOLOGY
- An epidemiology-based model as a tool to monitor the outbreak of inappropriateness in tumor marker requests: a national scale study
- (2016) Massimo Gion et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Prognostic Impact of the Initial Postoperative CA19-9 Level in Patients with Extrahepatic Bile Duct Cancer
- (2016) Yuichiro Kato et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Cell adhesion and polarity in squamous cell carcinoma of the lung
- (2016) Ester Bonastre et al. JOURNAL OF PATHOLOGY
- Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer
- (2016) Michela Capello et al. JNCI-Journal of the National Cancer Institute
- Optimize CA19-9 in detecting pancreatic cancer by Lewis and Secretor genotyping
- (2016) Guopei Luo et al. PANCREATOLOGY
- Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer
- (2016) Michela Capello et al. JNCI-Journal of the National Cancer Institute
- ReCAP: Serum Tumor Marker Use in Patients With Advanced Solid Tumors
- (2016) Melissa K. Accordino et al. Journal of Oncology Practice
- The cancer glycome: Carbohydrates as mediators of metastasis
- (2015) Siobhan V. Glavey et al. BLOOD REVIEWS
- Inflammation But Not Biliary Obstruction Is Associated With Carbohydrate Antigen 19-9 Levels in Patients With Primary Sclerosing Cholangitis
- (2015) Andreas Wannhoff et al. Clinical Gastroenterology and Hepatology
- Glycan Motif Profiling Reveals Plasma Sialyl-Lewis X Elevations in Pancreatic Cancers That Are Negative for Sialyl-Lewis A
- (2015) Huiyuan Tang et al. MOLECULAR & CELLULAR PROTEOMICS
- Borderline resectable pancreatic cancer: A consensus statement by the International Study Group of Pancreatic Surgery (ISGPS)
- (2014) Maximilian Bockhorn et al. SURGERY
- At Which Stage of Gastric Cancer Progression Do Levels of Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 Increase? Application in Advanced Gastric Cancer Treatment
- (2014) Eui Soo Han et al. Journal of Gastric Cancer
- The expanding roles of the Sda/Cad carbohydrate antigen and its cognate glycosyltransferase B4GALNT2
- (2013) Fabio Dall'Olio et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- CA 19-9: handle with care
- (2013) Claudio Galli et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Transcriptional control of the B3GALT5 gene by a retroviral promoter and methylation of distant regulatory elements
- (2013) Aida Zulueta et al. FASEB JOURNAL
- Expression of carbohydrate-antigen sialyl-Lewis a on colon cancer cells promotes xenograft growth and angiogenesis in nude mice
- (2013) Laura Terraneo et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- CA19.9 antigen circulating in the serum of colon cancer patients: Where is it from?
- (2013) Lydia Mare et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- α2,3-Sialyltransferase ST3Gal IV promotes migration and metastasis in pancreatic adenocarcinoma cells and tends to be highly expressed in pancreatic adenocarcinoma tissues
- (2013) Marta Pérez-Garay et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Prostatic Cell-Specific Regulation of the Synthesis of MUC1-Associated Sialyl Lewis a
- (2013) Vishwanath B. Chachadi et al. PLoS One
- Expression of ST3GAL4 Leads to SLex Expression and Induces c-Met Activation and an Invasive Phenotype in Gastric Carcinoma Cells
- (2013) Catarina Gomes et al. PLoS One
- Carbohydrate 19.9 Antigen Serum Levels in Liver Disease
- (2013) Gaetano Bertino et al. Biomed Research International
- The Spectrum of Hematologic Malignancies Involving the Pancreas
- (2012) Jonathan Rock et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Role of the ductal transcription factors HNF6 and Sox9 in pancreatic acinar-to-ductal metaplasia
- (2012) Pierre-Paul Prévot et al. GUT
- Colonic Epithelial Cells Express Specific Ligands for Mucosal Macrophage Immunosuppressive Receptors Siglec-7 and -9
- (2012) K. Miyazaki et al. JOURNAL OF IMMUNOLOGY
- Adjusting CA19-9 values to predict malignancy in obstructive jaundice: Influence of bilirubin and C-reactive protein
- (2012) Gaetano La Greca WORLD JOURNAL OF GASTROENTEROLOGY
- Human Monoclonal Antibodies to Sialyl-Lewisa (CA19.9) with Potent CDC, ADCC, and Antitumor Activity
- (2011) R. Sawada et al. CLINICAL CANCER RESEARCH
- Identification of blood-protein carriers of the CA 19-9 antigen and characterization of prevalence in pancreatic diseases
- (2011) Tingting Yue et al. PROTEOMICS
- The biosynthesis of the selectin-ligand sialyl Lewis x in colorectal cancer tissues is regulated by fucosyltransferase VI and can be inhibited by an RNA interference-based approach
- (2010) Marco Trinchera et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Identification of a Novel Type of CA19-9 Carrier in Human Bile and Sera of Cancer Patients: An Implication of the Involvement in Nonsecretory Exocytosis
- (2010) Naofumi Uozumi et al. JOURNAL OF PROTEOME RESEARCH
- Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report
- (2009) M. J. Duffy et al. ANNALS OF ONCOLOGY
- Synthesis of sialyl Lewisa (sLea, CA19-9) and construction of an immunogenic sLea vaccine
- (2009) Govind Ragupathi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Differential expression of α-2,3-sialyltransferases and α-1,3/4-fucosyltransferases regulates the levels of sialyl Lewis a and sialyl Lewis x in gastrointestinal carcinoma cells
- (2009) A.S. Carvalho et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Clinical significance of tumor markers and an emerging perspective on colorectal cancer
- (2008) Keishi Yamashita et al. CANCER SCIENCE
- Elevation of Carbohydrate Antigen 19.9 in Benign Hepatobiliary Conditions and Its Correlation with Serum Bilirubin Concentration
- (2008) S. L. Ong et al. DIGESTIVE DISEASES AND SCIENCES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now